Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AGHAEI MEYBODI FATEMEH; NAJAFIZADEH KATAYOUN; RAZAVI RATKI SEID KAZEM; NAMIRANIAN NASIM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Caspian Journal of Internal Medicine Year:2019 | Volume:10 | Issue:1 Page(s): 7-10

Download Full-Text

View:

155

Download:

Cites:

Information Journal Paper

Title

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis

Author(s)

AGHAEI MEYBODI FATEMEH | NAJAFIZADEH KATAYOUN | RAZAVI RATKI SEID KAZEM | NAMIRANIAN NASIM | Issue Writer Certificate

Keywords

Sirolimus

Lymphangioleiomyomatosis

Lung function

Abstract

Background: Lymphangioleiomyomatosis (LAM) is a progressive lungs disease that affects women at reproductive years. Sirolimus inhibits mammalian target of rapamycin (mTOR) and its administration in past studies was hopeful in treatment of patients with LAM. The aim of this study was to evaluate Sirolimus therapy on Lung function in LAM patients. Methods: We conducted a trial to evaluate the effect of Sirolimus on six patients with LAM who had severe or very severe obstructive lung disease, and one-year follow up. Maintenance level of Sirolimus was 10-15 ng/ml. Serial visits (including physical examination, evaluation of signs and symptoms of disease and adverse events due to treatment), spirometry, 6MWT done at baseline 3, 6, 9 and 12 months after. Spirometric parameters walk distance and O2 saturationbefore and after exercise at first and the end of treatment were measured. Results: Four patients had TSC-LAM while the other 2 patients had S-LAM. The mean level of Sirolimus was 13 ng/ml after one-year treatment. Mean FEV1 at enrollment and end of study was 1000cc (33% predict) and 1228cc (42% predict) respectively (P=0. 674). The mean FVC at baseline and end of study was 1648cc (49% predict) and 1866cc (55% predict) (P=0. 996). The mean FEV1/FVC at enrollment and the end of treatment was 58% and 62% respectively (P=0. 753). The mean FEF25-75 at first and at the end of treatment was 16% and 26%, respectively (P=0. 028). The mean walk distance in 6MWT at first and at the end of study was 315 meters (P=0. 9). The mean percentage of O2 saturation at rest was 84% and 92% at first and at the end of study (P=0. 104). Conclusion: In LAM patients, Sirolimus has been shown stabilizeto or improve Lung function, rest and exertional O2 saturation. Sirolimus was effective in LAM patients who had severe or very severe physiological disorders.

Cites

No record.

References

No record.

Cite

APA: Copy

AGHAEI MEYBODI, FATEMEH, NAJAFIZADEH, KATAYOUN, RAZAVI RATKI, SEID KAZEM, & NAMIRANIAN, NASIM. (2019). Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis. CASPIAN JOURNAL OF INTERNAL MEDICINE, 10(1), 7-10. SID. https://sid.ir/paper/323596/en

Vancouver: Copy

AGHAEI MEYBODI FATEMEH, NAJAFIZADEH KATAYOUN, RAZAVI RATKI SEID KAZEM, NAMIRANIAN NASIM. Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis. CASPIAN JOURNAL OF INTERNAL MEDICINE[Internet]. 2019;10(1):7-10. Available from: https://sid.ir/paper/323596/en

IEEE: Copy

FATEMEH AGHAEI MEYBODI, KATAYOUN NAJAFIZADEH, SEID KAZEM RAZAVI RATKI, and NASIM NAMIRANIAN, “Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis,” CASPIAN JOURNAL OF INTERNAL MEDICINE, vol. 10, no. 1, pp. 7–10, 2019, [Online]. Available: https://sid.ir/paper/323596/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops